Evidence map›Paper›PMID 36555395›Full record

ArticleInternational journal of molecular sciences2022

Ultrasensitive Detection of Multidrug-Resistant

Anshika Narang, Salvatore A E Marras, Natalia Kurepina, Varsha Chauhan, Elena Shashkina, Barry Kreiswirth, Mandira Varma-Basil, Christopher Vinnard, Selvakumar Subbian

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in International journal of molecular sciences, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Anshika NarangPublic Health Research Institute, New Jersey Medical School, Rutgers University, Newark, NJ 07103, USA.
Salvatore A E MarrasPublic Health Research Institute, New Jersey Medical School, Rutgers University, Newark, NJ 07103, USA.ORCID 0000-0003-2040-0354
Natalia KurepinaCenter for Discovery and Innovation, Nutley, NJ 07110, USA.
Varsha ChauhanDepartment of Microbiology, Vallabhbhai Patel Chest Institute, University of Delhi, Delhi 110021, India.
Elena ShashkinaCenter for Discovery and Innovation, Nutley, NJ 07110, USA.
Barry KreiswirthCenter for Discovery and Innovation, Nutley, NJ 07110, USA.
Mandira Varma-BasilDepartment of Microbiology, Vallabhbhai Patel Chest Institute, University of Delhi, Delhi 110021, India.ORCID 0000-0001-5562-015X
Christopher VinnardNew Jersey Medical School, Rutgers University, Newark, NJ 07103, USA.ORCID 0000-0002-0641-7814
Selvakumar SubbianPublic Health Research Institute, New Jersey Medical School, Rutgers University, Newark, NJ 07103, USA.ORCID 0000-0003-2021-8632

Funding

National Institute of Allergy and Infectious Diseases AI146820
6 · The paper itself

Abstract

The emergence of drug-resistant tuberculosis is a significant global health issue. The presence of heteroresistant

Indexed as

Mycobacterium tuberculosisTuberculosisTuberculosis, Multidrug-ResistantAntitubercular AgentsDNA, BacterialHumansIsoniazidMicrobial Sensitivity TestsMutationReal-Time Polymerase Chain ReactionAntitubercular AgentsDNA, BacterialIsoniazidanti-tuberculosis therapydrug resistancegenomic DNAisoniazidmolecular diagnosismutationReal-Time PCRrifampicin

Identifiers

PMID36555395
PMCPMC9779475

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.